371
U ÁP DNG B U TR
BNH NHÂN SUY TIM TI BNH VII HC HU
Hun, Hoàng Anh Tin
1
2
3
1
Bnh vii hc Y c Hu
2
i hc Oregon, Hoa K
3
i hc California, Hoa K
:
y
---Jude, Medtronic,
will be needed ./.
372
-
-
-
-
374
12/3
V
Gan to
7/8
4/15
TST
PR
QRS
14/15
96 ± 8,5 ck/phút
292 ± 128 ms
169 ± 28 ms
5/15
2
Thành công
14
1
P
TST
95± 21
84± 17
<0,05
HATT
90±9,6
100± 7,8
<0,05
HATTr
60±7,4
62± 4,7
NS
Dd(mm)
PAPS
(cm
2
)
20,67±4,9
70,11±7,1
48±5,1
7,9±4,1
27,99±5,7
58±6,9
47,6±7,3
5,7±1,3
32,22±6,8
54±5,4
45±6,9
5,3±1,0
37,44±5,9
51±5,4
42±8,1
4,9±0,7
40,7±5,6
50±6,7
37±9,3
4,5±0,4
40,5±6,1
48±6,8
33±8,21
4,3±0,6
39,6±4,8
2.0± 0,21
3.4± 0.3
2.0±0,17
3.2± 0,26
QRS (ms)
135± 4,2
127± 9,4
116± 2,9
121± 1,2
-
RS >120ms. EF = 35%. Dd = 60-70mm, EF = 25
-
-
-
-
1.
2. Gibson DG (2009). Effect of changé in ventricular activation on cardiac haemodynamic
in man. Br Heart J; 33: 397-400.
3. Lozano I (2002), VENTAK CHF/CONTAK CD InSync Randomized Clinical
Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med; 346: 1845-
1854.
4. John M. Miller and Douglas P. Zipes (2008), Diagnosis of Cardiac Arrhythmias,
Brawald, Heart diseease.
5. Lippincott Williams and Wilkins (2009), Disoder of The Cardiovascular System
, 18
th
Edition
6. Eric J. Topol, John D. Fisher (2008), Electrophysiology Testing, Test book of
Cardiovascular medicine. 1611-1632.
7. Abraham WT et al (2004). Effects of cardiac resynchronization on disease progression in
patients with left ventricular systolic dysfunction, an indication for an implantable
cardioverter-defibrilator, and mildly symptomatic chronic heart failure. Circulation; 110:
2864-2868.
8. Baxx JJ, et al (2003). Usefullness of cardiac tissue doppler echocardiography to evaluate
left ventricular dyssynchrony before and after biventricular pacing in patients with
idiophatic dilated cardiomyophathy. Am J Cardiol; 91: 94-97.
9. S. Serge Barold et al (2008). Device for cardiac Resynchronization Technologic and
Clinical Aspects.